Skip to main content
INCY
NASDAQ Life Sciences

欧洲委员会批准Incyte的Zynyz用于一线治疗进展性肛管癌

feedReported by Reuters
Sentiment info
Positive
Importance info
8
Price
$95.6
Mkt Cap
$19.093B
52W Low
$53.56
52W High
$112.29
Market data snapshot near publication time

summarizeSummary

Incyte获得欧洲委员会对Zynyz（retifanlimab）的批准，用于一线治疗进展性鳞状细胞癌（SCAC）肛管癌。这一重要的监管里程碑确立Zynyz为主要市场的一种首选治疗方案。该批准是在欧洲药品管理局（EMA）的委员会最近为Incyte的另一款药物（Olumiant）做出积极推荐之后，这凸显了该公司在扩大欧洲市场存在方面的持续成功。这种发展是Incyte的一项重大积极因素，预计将有助于未来收入增长，并加强其肿瘤学产品组合。交易者现在将关注Zynyz在整个欧洲的商业推出和销售表现。

在该公告发布时，INCY的交易价格为$95.60，交易所为NASDAQ，所属行业为Life Sciences，市值约为$190.9亿。 52周交易区间为$53.56至$112.29。 这则新闻被评估为积极市场情绪，重要性评分为8/10。 来源：Reuters。

show_chartPrice Chart

Share this article

Copied!

feed INCY - Latest Insights

INCY
Apr 28, 2026, 4:25 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Incyte Details Strong 2025 Performance, Robust Pipeline, and Annual Meeting Proposals
Sentiment: Positive
View Wiseek Article
INCY
Apr 28, 2026, 4:02 PM EDT
Filing Type: 10-Q
Importance Score:
9
Incyte Reports Strong Q1 2026 Financials, Major Pipeline Progress, and Appoints New CFO
Sentiment: Positive
View Wiseek Article
INCY
Apr 28, 2026, 7:03 AM EDT
Filing Type: 8-K
Importance Score:
8
Incyte Reports Strong Q1 2026 Financial Results with 21% Revenue Growth and Positive Povorcitinib Phase 3 Data
Sentiment: Positive
View Wiseek Article
INCY
Mar 28, 2026, 3:00 PM EDT
Source: Reuters
Importance Score:
9
Incyte's Oral Skin Drug Povorcitinib Delivers Strong Long-Term Symptom Relief in Late-Stage Trials
Sentiment: Positive
View Wiseek Article
INCY
Mar 26, 2026, 8:38 AM EDT
Filing Type: 8-K
Importance Score:
7
Incyte Reorganizes Executive Leadership for Strategic Growth
Sentiment: Neutral
View Wiseek Article
INCY
Mar 06, 2026, 5:03 PM EST
Filing Type: 8-K
Importance Score:
7
FDA Issues Complete Response Letter for Zynyz in NSCLC Due to Manufacturing Site Issues
Sentiment: Negative
View Wiseek Article
INCY
Mar 06, 2026, 4:56 PM EST
Source: Reuters
Importance Score:
8
European Commission Approves Incyte's Zynyz for First-Line Advanced Anal Canal Cancer
Sentiment: Positive
View Wiseek Article
INCY
Feb 27, 2026, 9:23 AM EST
Source: Dow Jones Newswires
Importance Score:
7
EU Committee Backs Olumiant for Adolescent Alopecia Areata, Positive for Incyte
Sentiment: Positive
View Wiseek Article
INCY
Feb 10, 2026, 6:31 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Major Investor Baker Bros. Secures Rights to Sell 15.3% Stake in Incyte
Sentiment: Negative
View Wiseek Article
INCY
Feb 10, 2026, 4:01 PM EST
Filing Type: 10-K
Importance Score:
9
Incyte Reports Strong 2025 Financials, Major Pipeline Wins & Favorable Novartis Settlement
Sentiment: Positive
View Wiseek Article